MEDIACENTER

All dissemination material of Immune-Image developed during the project will be available here, including project brochures to target audiences, partners interviews and regular newsletters.

BROCHURES

Scientist brochure

Scientist brochure

The Immune-Image project aims to develop and implement a novel non-invasive molecular imaging platform for assessing immune cell activation and dynamics in oncology and inflammatory diseases, both in animal models and in patients. If you would like to read more about...

Patient brochure

Patient brochure

The Immune-Image project is seeking to develop a new strategy to help doctors diagnose patients with conditions where the immune system is key. If you would like to read more about this research project, see the partners involved and get to know what it could mean to...

Immune cells in the spotlight

Immune cells in the spotlight

Innovative Medicines Initiative awards 30 Million Euro grant supporting research into novel tracer strategies for clinical imaging of immune cell dynamics The Innovative Medicines Initiative Joint Undertaking (IMI2 JU) project ‘Immune-Image’ has been approved for...

VIDEOS

Animation video: Immune-Image project explained

Animation video: Immune-Image project explained

The Immune-Image project aims to develop and implement a novel non-invasive molecular imaging platform for assessing immune cell activation and dynamics in oncology and inflammatory diseases, both in animal models and in patients. If you would like to know more about...

Interviews

Interview Manfred Kneilling

Interview Manfred Kneilling

Manfred Kneilling from the University of Tübingen is leading work package 4 of the Immune-Image project together with Bastian Zinnhardt from Roche. In this work package they evaluate the specificity and suitability of new immunotracers targeting different immune cells...

Meet the patient: Tom van der Wal

Meet the patient: Tom van der Wal

We interviewed Tom van der Wal from The Netherlands about his experiences with immunotherapy. Tom has Multiple Myeloma (Kahler) and was diagnosed in 2016, treated in VUmc Amsterdam, and was in remission in 2017. Unfortunately, the Multiple Myeloma returned in 2021. We...

Meet the partner: University of Cambridge

Meet the partner: University of Cambridge

Kevin Brindle is Professor of Biomedical Magnetic Resonance in the Department of Biochemistry at the University of Cambridge and a Senior Group Leader in the Cancer Research UK Cambridge Institute. The current focus of his work is to develop novel imaging methods to...

Meet the person behind the researcher: Claudia Foray

Meet the person behind the researcher: Claudia Foray

Claudia Foray is a researcher for the Immune-Image project and is involved in the project because of the focus of her PhD project. In her research she tries to understand therapy-induced modification of the tumor microenvironment in glioma models using molecular...

Meet the partner: Lygature

Meet the partner: Lygature

Within Immune-Image, Lygature co-leads the data management work package, WP2, taking overall responsibility for the timely delivery of the deliverables and milestones in the various subtasks and the creation and execution of the data management plan. It is Lygature's...

Patient interview: Seamus Cotter

Patient interview: Seamus Cotter

We interviewed Seamus Cotter from Ireland about his experiences with immunotherapy. Seamus has stage IV NSCLC lung cancer, was diagnosed in June 2016, and is now in remission. We asked him how he found out about immunotherapy, which treatment he received, and what his...

Interview Conny van der Laken

Interview Conny van der Laken

Conny van der Laken is a rheumatologist and a principal investigator of advanced imaging studies in rheumatology at the University of Amsterdam. Within the Immune-Image project, she is leader of Task 6.5, in a work package linked to patient research. Her research...

Meet our partner: Kevin Maresca from Pfizer

Meet our partner: Kevin Maresca from Pfizer

Kevin Maresca works in Early Clinical Development within Pfizer’s Worldwide Research, Development and Medical (WRDM) organization. He is head of PET/Molecular Imaging within the Digital Medicine and Translational Imaging group. We talked with Kevin about the role of...

Newsletters

Newsletter May 2021

Newsletter May 2021 открытие заявка на ипотеку

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 831514. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.